Acne: the full therapy pathway

The practical test is a fair over-the-counter trial: about 12 weeks of consistent, correct use of proven actives. If your acne hasn't meaningfully improved by then, that's the signal to see a clinician rather than to keep swapping products. Some acne — deep nodules or cysts, anything scarring, or acne causing real distress — warrants a clinician from the start, without waiting out that clock.

Its reputation runs well ahead of the reality for most patients. It is the most effective acne treatment there is and is strongly recommended for severe, scarring, or refractory disease, used under close supervision with routine blood monitoring. Its one non-negotiable is pregnancy: it causes severe birth defects and must never be taken in pregnancy, which is why the US iPLEDGE program enforces pregnancy prevention and testing throughout.

Oral antibiotics do have a role in moderate inflammatory acne, but guidelines deliberately keep them time-limited and always paired with a topical — usually including benzoyl peroxide — to limit antibiotic resistance. A topical antibiotic on its own isn't used at all for the same reason. The aim is to use the antibiotic to gain control, then carry the result forward with treatments that don't drive resistance.

The standard sequence is to control the acne first, then treat scars. Working on scars while acne is still active means treating a moving target and risking new scars alongside the ones being treated. Once the disease is controlled, the right scar procedure depends on the scar type — tethered rolling scars, broad texture, and narrow icepick scars are each matched to different techniques.

A few are far enough along to mention honestly. The prescription adapalene-plus-benzoyl-peroxide combination became available over-the-counter in the US in 2026, and candidates like a once-weekly topical (DMT310) and an oral sebum-suppressing drug (denifanstat) are in phase 3 development. None of that changes what to do now — if your acne warrants treatment today, waiting for a pipeline drug isn't the move.

Substantially, and it's worth raising first. Several first-line acne treatments are avoided in pregnancy — topical and oral retinoids, isotretinoin, spironolactone, and oral tetracyclines among them — while options like azelaic acid and, generally, benzoyl peroxide are more often considered compatible. Because the specifics depend on your situation, pregnancy status is something to state up front so a clinician can build a safe plan around it.

Real acne produces a mix of lesion types — blackheads, whiteheads, inflamed papules, sometimes cysts. A field of identical bumps is usually something else.

The single most useful thing to look at is variety. Acne vulgaris is a mixed eruption: open comedones, closed comedones, inflamed papules and pustules, and in more severe disease nodules and cysts, usually appearing together and usually in the oil-rich zones — face, chest, upper back. Monomorphic eruptions, where every lesion is the same size and shape, point elsewhere. Uniform itchy pustules scattered across the forehead, chest and shoulders suggest Malassezia folliculitis. Central redness with flushing and visible vessels but no comedones at all suggests rosacea. Recurrent painful lumps in the armpits, groin or under the breasts are a different condition again. Timing helps too: acne is chronic and waxes and wanes over months, so an eruption that appeared over a few days after a new medication, product or illness deserves a different explanation. None of this replaces someone looking at your skin, and the cost of a wrong premise is high — it buys you months of correct treatment for a condition you do not have.

Adult-onset acne is genuinely common, particularly in women, and it usually arrives as a lower-face and jawline pattern with a stronger hormonal component.

Nothing has gone wrong with you. Acne is not a teenage condition that occasionally lingers; a substantial share of adult women and a smaller share of adult men have it, and a meaningful subset never had it as teenagers at all. The adult presentation tends to differ: fewer comedones across the forehead, more deep tender papules along the jawline, chin and neck, often flaring in the week before a period and often more persistent than teenage acne. The drivers are usually hormonal fluctuation rather than a hormonal disease — although new adult acne alongside irregular periods, unusual hair growth or hair thinning is worth investigating properly. Stopping a contraceptive, starting or stopping other medication, and significant stress can all coincide with onset. The practical consequence is that the teenage playbook fits poorly. Aggressive drying agents aimed at oiliness tend to disappoint on adult skin that is also drier and slower to recover, and the treatments with the best evidence in this group are hormonal ones a clinician prescribes.

No — acne forms inside the follicle from sebum, abnormal shedding and inflammation, which no amount of surface washing reaches, and over-washing actively sets you back.

This is the most persistent and most damaging belief attached to the condition, because it is not only wrong but also actively counterproductive and quietly cruel. The plug that starts every lesion forms below the surface, in the follicle, out of your own sebum and skin cells. Surface dirt does not cause it, and the dark colour of a blackhead is oxidised keratin and lipid, not trapped grime. Washing twice a day with something gentle is the right dose. Beyond that, the returns turn negative: repeated cleansing, hot water, scrubs and astringents strip barrier lipids, provoke irritation, and make the medicated treatments that genuinely work far harder to tolerate — which is the real cost, because tolerance is what determines whether anyone stays on treatment long enough for it to work. The social version of this myth is worth naming too. People with acne are routinely assumed to be unhygienic, and that assumption is baseless. Acne tracks genetics and hormones, not cleanliness.

Adapalene for almost everyone, because it works on the plug every lesion begins as. Benzoyl peroxide joins it if you have inflamed spots rather than just bumps.

Start by naming what you have. Small flesh-coloured bumps and blackheads with little redness are comedonal acne, and the retinoid is the answer — adapalene 0.1%, available without a prescription, is the best-evidenced over-the-counter active there is. Red, sore papules and pustules mean inflammation is in the picture, and benzoyl peroxide addresses a different part of the process. Most people have both, which is why the two together outperform either alone. That is the piece most people get wrong: these are not competing options to trial one at a time, they are complementary mechanisms meant to be used together. The reason to introduce them a few weeks apart is tolerance, not evidence-gathering. Salicylic acid is the reasonable third option for oily, congested skin that cannot tolerate a retinoid yet, and azelaic acid is the gentler all-rounder worth knowing about if you are pregnant, easily irritated, or as concerned about the marks as the spots. A fixed-dose adapalene and benzoyl peroxide combination is now sold over the counter in the US, which collapses the whole decision into one tube.

Purging appears where you normally break out, arrives within the first six weeks, and settles. A reaction spreads to new areas, itches or burns, and keeps escalating.

Purging is real but narrower than the internet uses it. It happens with ingredients that accelerate follicular turnover — retinoids above all — and it is the microcomedones already present being pushed to the surface early. So the pattern is diagnostic. Genuine purging appears in your usual problem zones, consists of the kind of lesions you normally get, starts within days to a couple of weeks, and is fading by week six to eight. An adverse reaction shows up where you do not usually break out, often as small uniform bumps, a rash, or itching and stinging that persists after application rather than passing in minutes, and it gets worse week on week instead of better. A useful control question: does this ingredient plausibly cause purging at all? A moisturiser, a cleanser, an oil or a niacinamide serum has no mechanism for it, so bumps after starting one of those are a reaction or a coincidence, not a purge. If it is still worsening after eight weeks, stop calling it purging.

Mild flaking, tightness and brief stinging in the first weeks are expected. Sustained burning, swelling, weeping or redness spreading past where you applied are not.

Retinoid dermatitis — dryness, fine flaking around the nose and mouth, some pinkness, a few seconds of tingle on application — affects most people starting treatment and typically settles over four to six weeks as the skin adapts. It is uncomfortable rather than harmful, and it is the price of the mechanism that makes retinoids the most useful class in acne. Knowing which side of the line you are on matters, though. Expected: transient, mild, improving week on week, confined to where the product went, no itch. Not expected: burning that persists for hours, visible swelling, blistering or weeping, intense itch, redness extending well beyond the application area, or symptoms escalating rather than settling after six weeks. That second picture suggests an irritant reaction that has gone too far or a genuine contact allergy, and pushing through it is not toughness. The usual cause of severe reactions is dosing rather than the drug — too much, too often, too soon, on skin that was already compromised.

It can degrade tretinoin on contact, which is why those two are traditionally separated. Adapalene was designed to be stable with it, so same-application use is fine.

This warning is real, specific, and routinely over-generalised. Benzoyl peroxide is an oxidiser, and laboratory work showed it degrading tretinoin substantially when the two were applied together — hence the long-standing advice to use one in the morning and the other at night. Adapalene is a different molecule, engineered for photostability and chemical stability, and it does not suffer the same degradation; a fixed-dose product combining adapalene and benzoyl peroxide in a single tube has been sold for years and is now available over the counter in the US. Newer tretinoin formulations using microsphere or polymeric delivery are also considerably more robust than the original gels. The practical rules: adapalene plus benzoyl peroxide, same application, no problem. Plain tretinoin plus benzoyl peroxide, separate them by time of day. If you are unsure which formulation you have, separating them costs nothing and removes the question. What genuinely matters more than the sequencing is that both are being used at all, since the combination outperforms either alone.

Population-level evidence does not show increased risk — a meta-analysis of over 1.6 million patients found no rise in suicide or psychiatric disorders among users.

This is the fear that keeps people away from the most effective acne treatment available, and it deserves a careful rather than a reassuring answer. The concern dates to case reports and a 2005 FDA black box warning covering depression, suicide, aggression and psychosis. The epidemiology since has not supported a causal link: a 2024 meta-analysis in JAMA Dermatology pooling 25 studies and more than 1.6 million patients found no increased relative risk of suicide or psychiatric disorders in isotretinoin users, and found users less likely to attempt suicide two to four years after treatment than non-users. That last finding fits what clinicians observe, since severe acne itself carries a substantial psychological burden that effective treatment relieves. None of this means nobody experiences a mood change on the drug. Individual reactions exist, monitoring mood during a course remains standard advice, and anyone with a psychiatric history should have that discussed openly rather than concealed. The honest position is that the population-level alarm has not been borne out, while individual vigilance still makes sense.

Azelaic acid is the usual first choice, with topical benzoyl peroxide, clindamycin and erythromycin also considered compatible. All retinoids and isotretinoin are out.

The absolute rule first: oral isotretinoin causes severe birth defects and must never be taken in pregnancy, and topical retinoids — tretinoin, adapalene, trifarotene — are avoided as a precaution even though systemic absorption is minimal. Oral tetracyclines are also avoided, affecting fetal bone and tooth development after the first trimester. What remains is genuinely useful. Azelaic acid is the most commonly recommended option, with anti-inflammatory, anticomedonal and pigment-fading effects and no signal of harm in animal work. Topical benzoyl peroxide is regarded as compatible, with minimal systemic absorption, generally used over limited areas. Topical clindamycin and erythromycin are considered acceptable for inflammatory acne, ideally paired with benzoyl peroxide to limit resistance. Salicylic acid in low-concentration topical form is usually considered acceptable; oral salicylates and high-strength peels are not. Pregnancy acne often worsens in the first trimester and improves later, so a mild plan that runs the whole way is generally better than switching repeatedly. Confirm your specific plan with your obstetric team rather than inferring it from a label.

Inflammation triggers melanocytes to deposit extra pigment, and melanin-rich skin responds more strongly. The mark is not a scar and it is not permanent.

Post-inflammatory hyperpigmentation is the pigment system responding to injury. Inflammatory mediators released during a lesion stimulate melanocytes, which deposit melanin into the epidermis and sometimes deeper into the dermis; the more active the pigment system, the more pronounced the response, which is why this is the dominant complaint in richly pigmented skin and why it frequently outlasts the acne by many months. Two distinctions matter. A flat brown or grey-brown mark is pigment and will fade. A flat red or purple mark is dilated vessels — post-inflammatory erythema — and behaves differently. Neither is a scar; a scar is a change in the skin's contour, a pit or a raised area, and no amount of fading cream alters one. What deepens and prolongs pigment marks is more inflammation and more ultraviolet exposure, which is why picking, harsh scrubs and skipping sunscreen extend the timeline far more than most people realise. Daily broad-spectrum sunscreen is not cosmetic advice here; it is the single most effective thing preventing today's spot from lasting a year.

Clear skin is the treatment working, not the condition ending. Stopping usually means relapse within a few months; maintenance therapy is the standard plan.

This is the most common reason people cycle in and out of treatment for years. Acne is a chronic condition with a tendency to remit rather than an infection that gets cured, and the underlying process — follicular plugging driven by sebum and inflammation — resumes when the thing suppressing it stops. Guidelines therefore treat maintenance as part of the plan rather than an optional extra, and the maintenance agent is usually a topical retinoid, sometimes with benzoyl peroxide, applied at a frequency you can sustain indefinitely. What can reasonably stop is the heavier machinery: oral antibiotics were always meant to be time-limited, and the topical regimen is what should be carrying you afterwards. Reducing rather than stopping is often achievable — nightly to three or four nights a week — and the way to find your floor is to step down gradually and watch, rather than stopping entirely and rediscovering the answer the hard way. If clear skin has held for a year on a reduced regimen, a supervised trial off treatment is reasonable.

Sudden severe ulcerating acne with fever, joint pain or feeling unwell needs same-week medical care. So does any acne that is actively scarring.

Most acne is not urgent, and the small number of presentations that are share a common feature: they involve the whole person rather than only the skin. Acne fulminans is the clearest example — an abrupt eruption of severe, painful, ulcerating or crusted nodules, usually on the trunk, accompanied by fever, malaise, joint or bone pain, and sometimes appearing shortly after starting isotretinoin. That combination needs prompt medical assessment, not a change of skincare, because it is treated with systemic corticosteroids alongside careful reintroduction of acne therapy. Other reasons not to wait: rapidly worsening severe acne in someone who is systemically unwell; a lesion that is spreading, hot and exquisitely painful with surrounding redness, which suggests infection rather than acne; sudden severe acne with other hormonal changes such as voice deepening or rapid hair growth; and any acne that is visibly leaving pits or raised scars, where the urgency is about the closing window rather than about danger. In all of these, the correct next step is a clinician.

Three things: drain or inject an individual lesion, prescribe drugs that act on sebum production, and treat scarring — none of which any topical can do.

The honest division of labour is worth stating plainly, because it decides whether you are wasting money. Topicals and over-the-counter products act on the follicle plug and on surface bacteria, and they do that well. What a clinic adds falls into three categories. First, single-lesion intervention: an intralesional corticosteroid injection flattens an angry nodule in a day or two, and drainage of a large cyst relieves pressure — both are minutes of work with immediate effect. Second, systemic treatment that reduces sebum production or hormonal drive, which no cream can reach. Third, anything to do with scarring, where lasers, microneedling, subcision and TCA CROSS are the only tools that exist. Devices aimed at active acne, such as the 1726-nm sebaceous-gland laser, sit somewhere between the second and third categories and are newer. What a clinic cannot do is produce a durable result while the underlying routine is neglected — procedures are additions to a regimen rather than replacements for one.

Treat the eczema first and stabilise the barrier, then reintroduce acne actives slowly. Inflamed, permeable skin cannot tolerate a retinoid, and forcing it fails both.

These conditions pull in opposite directions: acne treatment removes and dries, eczema treatment restores and occludes. Trying to run both at full intensity produces a barrier that fails, at which point the acne treatment becomes intolerable and gets abandoned. Sequence solves most of it. Settle the eczema first with emollients used generously and whatever topical anti-inflammatory has been prescribed, and give it a couple of weeks. Then reintroduce one acne active at low frequency, applied only to acne-prone areas rather than the eczema-prone ones — the two rarely occupy identical territory, and treating regionally is entirely legitimate. Choose the gentler options: azelaic acid over a strong retinoid, a non-foaming cleanser, benzoyl peroxide sparingly and not on eczematous skin. Moisturise before the active rather than after if stinging is the limiting factor. If both are moderate and neither can be controlled without upsetting the other, that is a genuine reason to be seen rather than a routine to be perfected at home.

Look for a named active at a stated percentage near the top of the ingredient list. Everything on the front of the pack is marketing until that is present.

Three checks settle most decisions in about twenty seconds. First, find the active: adapalene, benzoyl peroxide, salicylic acid or azelaic acid, with a percentage. In the US, genuine acne drugs carry a Drug Facts panel listing the active and its strength, which is a stronger signal than any front-of-pack claim. Second, check where things sit in the ingredient list, which is ordered by concentration down to 1%: a heavily advertised botanical appearing after the preservatives is present in trace amounts. Third, read what the claim actually says — a product that promises to help skin look clearer is making a cosmetic claim, while one stating it treats acne is making a drug claim and is regulated accordingly. Two extras worth a glance for acne-prone skin: alcohol denat high in the list on a leave-on product, and fragrance or parfum if you are prone to reacting. What carries no information at all: dermatologist-tested, clinically proven, and clean.